Clinical Trial Update: A Phase 2, Pharmacokinetic (PK) Study of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Endothelial Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study of 6R-BH4 alone or with vitamin C in subjects with endothelial dysfunction completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction

Drugs mentioned

• 6R-BH4 (6R-tetrahydrobiopterin)
• Vitamin C (ascorbic acid)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Endothelial Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2021-05-17